Active ingredient
- terbinafine hydrochloride
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 08553/0213.
Terbinafine 250mg Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Terbinafine 250mg Tablets
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet:
1. What Terbinafine Tablets are and what they are used for
2. What you need to know before you take Terbinafine Tablets
3. How to take Terbinafine Tablets
4. Possible side effects
5. How to store Terbinafine Tablets
6. Contents of the pack and other information
1. What Terbinafine Tablets are and what they are used for
Terbinafine is an antifungal medicine used to treat fungal skin and nail infections.
2. What you need to know before you take Terbinafine Tablets
DO NOT take Terbinafine Tablets
Warnings and precautions
Talk to your doctor or pharmacist before taking Terbinafine Tablets. If the answer to any of these questions is YES, Terbinafine Tablets might not be the right medicine for you.
Children and adolescents
Children should not normally be given Terbinafine Tablets.
Other medicines and Terbinafine Tablets
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Some medicines can interfere with your treatment. Tell your doctor if you are taking any of the following:
You should have blood tests before and during treatment with Terbinafine Tablets to monitor your liver function.
Driving and using machines
Some people have reported feeling dizzy or giddy while they are taking Terbinafine Tablets. If you feel like this, you should not drive or operate machinery.
3. How to take Terbinafine Tablets
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The usual dose for adults, including the elderly is 250 mg once a day.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
If you take more Terbinafine Tablets than you should
All tablets can be risky if you take too many. If you take too many Terbinafine Tablets at once, tell your doctor or hospital casualty department as soon as possible Take your medicine pack with you so that people can see what you have taken.
If you forget to take Terbinafine Tablets
Take one as soon as you remember unless it is nearly time to take the next one. Do not take two tablets to make up for the forgotten one. If you are unsure, ask your doctor or pharmacist.
If you have any further questions on the use of this medicine ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Any side effects are usually mild or moderate and don’t last for too long.
Some side effects can be serious
Stop taking the tablets and tell your doctor immediately if you notice any of the following rare symptoms:
The most common side effects are:
The side effects listed below have also been reported.
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (frequency cannot be estimated from the available data)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Terbinafine Tablets
Keep in the original packaging. Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date which is stated on the blister, carton or label. The expiry date refers to the last day of that month.
Do not use this medicine if you notice signs of deterioration such as discolouration or crumbling.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
What Terbinafine Tablets contain
The active substance is terbinafine.
Terbinafine 250 mg Tablets contain 250 mg of the active ingredient terbinafine.
Terbinafine 250 mg Tablets also contain the inactive ingredients magnesium stearate (E470b), colloidal anhydrous silica, hypromellose (E464), microcrystalline cellulose (E460) and croscarmellose sodium (E468).
What Terbinafine Tablets look like and contents of the pack
Terbinafine 250 mg Tablets are round white to off-white flat tablets with a break line on one side. The tablets are marked R250 on the reverse side.
The tablets are available in: blister packs of 14, or 28 tablets or bottles of 60, 100 or 500 tablets. Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
This leaflet was last revised in January 2022
6 Riverview Road, Beverley, Hull, HU17 0LD
+44 (0)1482 860228
+44 (0)1748 828873
+44 (0)1482 389858
+44 (0)1482 860204
+44 (0)1748 828801